Upregulated hepatic expression of mitochondrial PEPCK triggers initial gluconeogenic reactions in the HCV-3 patients

Asian Pacific Journal of Tropical Medicine
Taimoor Islam SheikhIshtiaq Qadri

Abstract

To identify the differential expression of candidate gluconeogenic genes which may initiate hepatitis C virus (HCV) related metabolic disorder during early stages of disease. Patients of diverse age and sex, with positive HCV genotype 3 (HCV-3) RNA in serum and with no history of other related infections, co-infections, alcoholism, diabetes or chemotherapeutic treatments were considered for this study. Semi-quantitative reverse transcriptase PCR analysis and quantitative fold change analysis of the fresh liver biopsies of eight chronically infected HCV-3 patients and six healthy individuals were evaluated for three potential biomarkers involved in glucose homeostasis induction, namely mitochondrial phosphoenolpyruvate carboxykinase 2 (PCK2), glucose-6-phosphatase catalytic subunit (G6PC) and associated forkhead box protein 01 (FOXO1). Symptomatic evaluation, clinical history and blood test were conducted according to general disease prognosis procedures and reported here. Significantly upregulated expression of PCK2 independent of age, sex and viral infectivity levels in all HCV patients was observed, whereas no significant changes in the expression of G6PC and FOXO1 were found. PCK2 triggers initial gluconeogenic reactions whi...Continue Reading

References

Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
May 26, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·David E KleinerUNKNOWN Nonalcoholic Steatohepatitis Clinical Research Network
Aug 22, 2007·Cell Biochemistry and Biophysics·Elmus G BealeClaude Forest
Aug 12, 2009·Journal of Hepatology·Pierre-Yves BochudUNKNOWN Swiss Hepatitis C Cohort Study Group
Dec 5, 2009·World Journal of Gastroenterology : WJG·Yasir WaheedIshtiaq Qadri
Dec 31, 2009·Liver International : Official Journal of the International Association for the Study of the Liver·Venessa Pattullo, Jenny Heathcote
Aug 28, 2010·Molecular and Cellular Endocrinology·Mahua ChoudhuryJacob E Friedman
Aug 27, 2011·Clinics in Liver Disease·Mitchell L Shiffman
Jan 17, 2012·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Chiara GiordaninoGiorgio Saracco
Feb 17, 2015·Hepatitis Monthly·Mazaher Khodabandehloo, Daem Roshani

❮ Previous
Next ❯

Citations

Apr 6, 2019·Current Molecular Medicine·Venu SeenappaKapaettu Satyamoorthy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Hepatitis

Autoimmune hepatitis formerly called lupoid hepatitis, is a chronic, autoimmune disease of the liver that occurs when the body's immune system attacks liver cells causing the liver to be inflamed. Discover the latest research on autoimmune hepatitis here.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.